Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study. - Brewer, Molly; Angioli, Roberto; Scambia, Giovani; Lorusso, Domenica; Terranova, Corrado; Panici, Pierluigi Benedetti; Raspagliesi, Francesco; Scollo, Paolo; Plotti, Francessco; Ferrandina, Gabriella; Salutari, Vanda; Ricci, Caterina; et al. (Gynecologic Oncology, 2020)